At 100XBIO we strive to deliver 100x more data on antigen specificity of the T cells in the limited sample volume (blood, tumor, lymph nodes), and as the downstream -- confirming the cells' phenotype and cytokine expression.
Looking for (1) early investments, (2) R&D partners, and (3) early academia, biotech and pharma clients. We are raising $500K of pre-seed investment, and raised over $200K.
Company Details
- Employees
- 3
- Founded
- 2023
- Address
- 299 Washington St, Woburn,massachusetts 01801,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.100xbio.com/
- Keywords
- as we grow.
- HQ
- Woburn, Massachusetts
100xbio Questions
100Xbio's website is https://www.100xbio.com/
100Xbio's LinkedIn profile is https://www.linkedin.com/company/100xbio
100Xbio has
3 employees.
View email and phone details for 3
employees at 100Xbio.
100Xbio's industry is
Biotechnology Research
100Xbio's top competitors are
Teleflex,
Vanderbilt Quantum Initiative,
Lila Sciences,
Advancedag,
Buckle Therapeutics Inc.,
Forming Lives Foundation Inc,
Maplight Therapeutics, Inc.,
Greenlight Biosciences,
Genezen,
Breakbio Corp.
100Xbio's categories are Biotechnology Research
100Xbio's founding year is 2023
